Eli Lilly has enrolled the first patient into a phase 3 trial that is seeking to repurpose arthritis drug Olumiant as a treatment for people with COVID-19.
Artificial intelligence (AI) has now moved beyond its initial hype towards becoming a key part of the pharma industry – with many companies looking to partner with AI drug discovery start-u
Researchers in the UK say they developed an artificial intelligence-based computer model that can reliably detect COVID-19 in X-rays, which could help assist diagnoses when cor